FDA NDC Directory · JSON-LD · Markdown
NDC 68016-813 · HUMAN OTC DRUG · CAPSULE, LIQUID FILLED
| Labeler / Manufacturer | Chain Drug Consortium, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA206568 |
| Dosage form / route | CAPSULE, LIQUID FILLED · ORAL |
| Active ingredients | IBUPROFEN (200 mg/1) |
| Marketing started | 20220826 |
| Marketing ended | 20261231 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).